Jagpal Netta 4
4 · InMed Pharmaceuticals Inc. · Filed Dec 19, 2025
Insider Transaction Report
Form 4
Jagpal Netta
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-12-19+18,000→ 24,250 totalExercise: $1.29Exp: 2030-12-18→ Common shares (18,000 underlying)
Footnotes (1)
- [F1]The options were granted on 12/19/2025 and will vest in equal installments monthly, in arrears, over 36 months (1/36 per month)